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Éva A. Enyedy*a
Complex formation processes of [Ru(η6-p-cymene)(H2O)3]+ and [Rh(η5-C5Me5)(H2O)3]+ organometallic
cations with 8-hydroxyquinoline (HQ) ligands were studied in aqueous solution by the combined use of
1H NMR spectroscopy, UV-visible spectrophotometry and pH-potentiometry. Solution stability, chloride
ion aﬃnity and lipophilicity of the complexes were characterized together with the in vitro cytotoxicity
against a pair of cancer cell lines, responsive and resistant to classic chemotherapy. The solid phase struc-
ture of the [Rh(η5-C5Me5)(8-quinolinolato)(Cl)] complex was characterized by single-crystal X-ray diﬀrac-
tion analysis. In addition to the unsubstituted HQ its 7-(1-piperidinylmethyl) (PHQ) and 5-sulfonate (HQS)
derivatives were involved. PHQ has a signiﬁcant preference for targeting multidrug resistant cancer cell
lines, while HQS served as a water soluble model compound. The equilibrium studies revealed the for-
mation of mono[M(L)(H2O)] complexes with prominently high solution stability, which predominate at
physiological pH even in the micromolar concentration range, and the formation of mixed hydroxido
[M(L)(OH)] complexes was characterized by relatively high pKa values (8.5–10.3). In comparison to the
Rh(η5-C5Me5) species the complexation process with Ru(η6-p-cymene) is much slower, and both the pKa
values and the H2O/Cl
− co-ligand exchange constants are lower by 1–1.5 orders of magnitude. The stabi-
lity order obtained for these organometallic complexes is as follows: HQS > HQ > PHQ. The cytotoxicity
of the ligands and their Ru(η6-p-cymene) and Rh(η5-C5Me5) complexes was investigated against MES-SA
(human uterine sarcoma) cell line and its multidrug resistant counterpart (MES-SA/Dx5). HQ and its com-
plexes show similar cytotoxicity in both cell lines. In contrast, PHQ and its Rh(η5-C5Me5) complex are
more potent against MES-SA/Dx5 cells, while this selectivity could not be observed for the Ru(η6-p-
cymene) complex.
Introduction
Resistance and the serious side eﬀects associated with the use
of anticancer platinum drugs used in chemotherapy are still
driving for the design and development of novel metal-based
compounds that combine good eﬃcacy, selectivity and low sys-
temic toxicity due to their diﬀerent modes of action and phar-
macokinetics. Ruthenium complexes have been the subject of
extensive drug discovery eﬀorts, yielding e.g. the sodium trans-
[tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339, IT-139)
and imidazolium trans-[tetrachlorido(DMSO)(imidazole)ruthe-
nate(III)] (NAMI-A) as the most promising compounds reaching
clinical trials.1–4 These ruthenium(III) complexes are con-
sidered as prodrugs activated by reduction. Organoruthenium(II)
compounds have gained increasing attention recently and
numerous [Ru(η6-arene)(X)(Y)(Z)] complexes were found to be
active as antitumor compounds.5 One of the most well-known
ruthenium(II) arene complexes [Ru(η6-p-cymene)Cl2(PTA)]
(PTA = 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decane) shows
anti-metastatic properties and is ready for translation to clini-
cal evaluation.6 In most of the half-sandwich organoruthe-
nium(II) compounds a bidentate ligand with an (O,O), (O,S),
(O,N), (N,N) or (N,S) binding mode is coordinated and a
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chloride ion acts as the leaving group.7–11 The replacement of
the chlorido ligand by a water molecule facilitates the reaction
with biological macromolecules such as proteins or DNA,12
while the chelating ligand allows modifications of the chemi-
cal properties, ligand exchange rate, lipophilicity, 3D shape
and ultimately influences the pharmacological eﬀect.
Rhodium(III) is isoelectric with ruthenium(II) and the coordi-
nation of e.g. the anionic pentamethylcyclopentadienyl
(C5Me5
–) ligand results in faster ligand exchange kinetics.13
Promising in vitro antitumor activity has been reported for Rh
(η5-C5Me5) complexes of (N,N) donating polypyridyl ligands by
Sheldrick and his co-workers.14,15 Recently we reported Rh(η5-
C5Me5) complexes formed with (O,O) donor hydroxypyr(id)
ones (maltol, deferiprone) showing moderate cytotoxicity on
various cancer cell lines,16,17 while the complexes of (N,O)
donor picolinates exhibited only poor anticancer activity.17,18
Both Rh(η5-C5Me5) and Ru(η6-p-cymene) half-sandwich com-
plexes of the (N,O) donor 8-hydroxyquinoline (HQ, Chart 1) are
reported to possess antitumor activity with IC50 values in the
low micromolar concentration range.19–21 These complexes
were characterized by standard analytical methods19–24 and in
the case of the [Ru(η6-p-cymene)(L)(Cl)] and [Ru(η6-p-cymene)
(L)(H2O)]
+ (L: 8-quinolinolato) in the solid state by single-
crystal X-ray diﬀraction analysis.23,24 Notably, in a set of Ru(η6-
p-cymene) half-sandwich complexes with 8-HQ derivatives it
was found that the introduction of halogens in positions R5
and R7 of the scaﬀold increased both anticancer cytotoxicity
and intracellular accumulation, suggesting that these two moi-
eties might be relevant for the fine tuning of the biological
activity of these complexes.21 Excellent cytotoxic eﬀect in
tumor cell lines was found for water soluble mixed-ligand
[Ru(η6-p-cymene)(8-quinolinolato)(H-azole heterocycle)]+ com-
plexes.20 In addition, Ru(η6-p-cymene) complexes of various
HQ derivatives have been found to catalyze the hydrogenation
of CO2 to formate in aqueous solution and the catalytic activity
showed strong pH-dependence.24 Although these 8-quinolino-
lato complexes have been extensively studied, their solution
speciation and stability constants are not available in the
literature. For the better understanding of the pharma-
cokinetic profile and mechanisms of action of these metal
complexes in addition to their pH-dependent catalytic activity,
the knowledge of the speciation and the most plausible chemi-
cal forms in aqueous solution, especially at physiological pH,
is a mandatory prerequisite. Therefore, one of the aims of the
present study was to characterize the solution speciation of Rh
(η5-C5Me5) and Ru(η6-p-cymene) complexes of HQ in aqueous
solution involving studies on their chloride ion aﬃnity and
lipophilicity.
HQ is a privileged structure, which appears frequently in
drugs, natural compounds, or bioactive molecules and is used
as a ligand in the orally active tris(8-quinolinolato)gallium(III)
complex (KP46), currently undergoing clinical trials.25,26 The
HQ derived Mannich base 7-(1-piperidinylmethyl)-HQ
(NSC57969, PHQ, Chart 1) has recently been identified to over-
come multidrug resistance (MDR) in cancer, a phenomenon
conferring resistance to a wide range of structurally and
mechanistically unrelated anticancer agents.27–29 Several
related derivatives have been identified to show paradoxically
enhanced cytotoxicity against MDR cell lines overexpressing
P-glycoprotein (P-gp), a transport protein mediating resistance
by eﬄuxing chemotherapeutic agents from cancer cells,
thereby keeping their intracellular concentrations below a cell-
killing threshold.27–30
In this work, our additional aim was to investigate the
complex formation processes of PHQ in comparison to the HQ
scaﬀold and the R5 substituted HQS with [Ru(η6-p-cymene)
(H2O)3]
+ and [Rh(η5-C5Me5)(H2O)3]+ cations and to reveal their
cytotoxic eﬀectiveness.
Results and discussion
Proton dissociation processes of the ligands (HQ, HQS, PHQ)
and hydrolysis of the organometallic cations
HQ and 8-hydroxyquinoline-5-sulfonate (HQS) (Chart 1) are
well-known compounds and their proton dissociation pro-
cesses have already been described in the literature.31–34 Due
to the insuﬃcient water solubility of HQ, HQS was involved in
the studies and considered as a model compound possessing
the same coordination mode as HQ. Notably, proton dis-
sociation constants of HQ and HQS (Table 1) were determined
herein by UV-visible (UV-vis) spectrophotometry and 1H NMR
spectroscopy (pH-dependent NMR spectra for HQS are shown
in Fig. S1†) at 1 mM concentration. Data obtained by the
diﬀerent methods under the chloride-free conditions are in
good agreement with each other and with the previously pub-
lished data obtained by pH-potentiometry.31 pK1 is attributed
to the deprotonation of the quinolinium (NH+) group and pK2
belongs to the hydroxyl moiety. The sulfonic acid group of
HQS is deprotonated in the whole pH range studied due to its
strong acidic character. Notably, the deconvolution of the UV-
vis spectra recorded at various pH values using ten times more
diluted conditions (cL ∼ 0.1 mM) gave lower pK1, and some-
what higher pK2 constants for both ligands (see the dissimilar
positions of the inflection points in Fig. S2† for the pH-depen-
dent absorbance values obtained for HQS at two kinds of
concentrations).
The concentration dependent pKa values of these compounds
might be the result of a slightly altered ratio of the α and β (or
cis/trans) HL forms35 under the two kinds of conditions.
The deprotonation of the piperidine derivative PHQ has
also two pKa values attributed to the same moieties as in the
Chart 1 Chemical structures of the ligands: 8-hydroxyquinoline (HQ),
8-hydroxyquinoline-5-sulfonate (HQS) and 7-(1-piperidinylmethyl)-8-
hydroxyquinoline (PHQ).
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case of HQ, but PHQ has 3 protonation sites, and the methyl-
piperidinium nitrogen is most probably protonated in the pH
range 2–11.5. The corresponding pKa values of PHQ and HQS
are significantly lower than those of HQ due to the electron
withdrawing eﬀect of the protonated piperidinium moiety and
the sulfonate substituent, respectively.
The hydrolytic behavior of the aquated organometallic
cations [Ru(η6-p-cymene)(H2O)3]2+ and [Rh(η5-C5Me5)(H2O)3]2+
has been studied previously.16,36–38 The structure of the major
hydrolysis products of [Rh(η5-C5Me5)(H2O)3]2+, the dimeric
[(Rh(η5-C5Me5))2(μ-OH)3]+ species was characterized by single-
crystal X-ray analysis39 and the similar structure is assumed for
the [(Ru(η6-p-cymene))2(μ-OH)3]+ complex based on 1H NMR
studies.40 Overall stability constants were reported for the
μ-hydroxido-bridged dinuclear ruthenium(II) species ([(Ru(η6-p-
cymene))2(μ-OH)3]+) by Buglyó et al.,36 and for the rhodium(III)
species [(Rh(η5-C5Me5))2(μ-OH)3]+, [(Rh(η5-C5Me5))2(μ-OH)2]2+) by
some of us,16 and were used in this work for the calculations.
Complex formation equilibria of [Rh(η5-C5Me5)(H2O)3]2+ with
HQ, HQS and PHQ
The complex formation equilibrium processes in the case of
the [Rh(η5-C5Me5)(H2O)3]2+–HQS system were found to be fast
and the species involved in the equilibria have good water
solubility. These features allowed us the combined use of pH-
potentiometry, 1H NMR spectroscopy and UV-vis spectro-
photometry in a chloride-free medium. Notably, HQS was used
as a model compound for HQ and PHQ, the biologically more
interesting compounds, as its good solubility in water allowed
us the simultaneous use of the various techniques. The com-
plexation between [Rh(η5-C5Me5)(H2O)3]2+ and HQS follows a
fairly simple scheme (Chart S1†), since a mono-ligand [Rh(η5-
C5Me5)(L)(H2O)] (= [ML]) complex is formed with this bidentate
ligand, and a mixed hydroxido [ML(OH)]− species appears
upon the deprotonation of the coordinated water molecule in
the basic pH range, similarly to the behavior of numerous
half-sandwich organorhodium complexes studied
previously.16–18,41 The pH-potentiometric titration data reveal
almost complete complex formation already at the starting pH
(∼2), therefore the stability constant of this [ML] type complex
(Table 2) was determined by deconvolution of UV-vis spectra
measured between pH 0.7 and 3.0 (Fig. 1a) (M always denotes
the metal ion moiety: [Rh(η5-C5Me5)(H2O)3]2+ or [Ru(η6-p-
cymene)(H2O)3]
2+).
These spectra were recorded for individual samples, in
which the KNO3 was partially or completely replaced by HNO3
Table 1 Proton dissociation constants (pKa) of the studied ligands HQ, HQS and PHQ determined by various methods {T = 25 °C; I = 0.2 M
(KNO3)}
a
Method cL
HQ HQS PHQ
pK1 pK2 pK1 pK2 pK1 pK2
pH-Metry 1 mM 4.99b 9.51b 3.90b 8.37b — —
1H NMR 1 mM — — 3.92(1) 8.38(1) — —
UV-Vis 1 mM 5.03(1) 9.66(1) 3.83(1) 8.39(1) — —
UV-Vis ∼0.1 mM 4.78(1) 9.74(1) 3.63(1) 8.48(1) 2.80(1) 6.93(1)
aUncertainties (SD) of the last digits are shown in parentheses. bData are taken from ref. 31.
Table 2 Stability constants (log K [ML]), pKa [ML] values of the Rh(η5-C5Me5) and Ru(η6-p-cymene) complexes formed with HQS, HQ and PHQ in
chloride-free aqueous solutions determined by various methods; H2O/Cl
− exchange constants (log K’) for the [Rh(η5-C5Me5)(L)(H2O)] and [Ru(η6-p-
cymene)(L)(H2O)] complexes {T = 25 °C; I = 0.2 M (KNO3)}
a
Method Constants HQS HQ PHQ
Rh(η5-C5Me5) UV-Vis log K [ML] 14.52(2)b 15.02(3) 12.38(6)b
UV-Vis pKa [ML] 10.10(1) 10.27(5) 10.08(2)
1H NMR pKa [ML] 10.12(1) — —
pH-Metry pKa [ML] 9.90(7) — —
UV-Vis log K′ (H2O/Cl
−)c 1.54(1) 1.81(1) 1.61(2)
Ru(η6-p-cymene) UV-Vis log K [ML] — 16.53(2)b 13.31(4)b
UV-Vis pKa [ML] 8.46(2) 9.19(4) 9.37(6)
1H NMR log K [ML] ≥16d — —
1H NMR pKa [ML] 8.52(3) — —
UV-Vis log K′ (H2O/Cl
−)c 0.64(4) 0.89(2) 1.19(2)
aUncertainties (SD) of the last digits are shown in parentheses. M denotes Rh(η5-C5Me5) and Ru(η6-p-cymene), respectively and aqua ligands and
the charges of the complexes are not shown for clarity. Hydrolysis products of the organometallic cations: log β [(Rh(η5-C5Me5))2H−2(H2O)2]2+ =
−8.53, log β [(Rh(η5-C5Me5))2H−3]+ = −14.26 and log β [(Ru(η6-p-cymene))2H−3]+ = −9.36 at I = 0.20 M (KNO3) taken from ref. 16 and 37.
bDetermined by UV-Vis spectrophotometry at pH 0.7–3.0. c For the [Rh(η5-C5Me5)(L)(H2O)]+ + Cl− ⇌ [Rh(η5-C5Me5)(L)Cl] + H2O and [Ru(η6-p-
cymene)(L)(H2O)]
+ + Cl− ⇌ [Ru(η6-p-cymene)(L)Cl] + H2O respectively, equilibria determined at various total chloride ion concentrations by
UV-Vis. d Estimated from the 1H NMR peak integrals of the ligand protons in the bound and unbound forms at pH 0.7.
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keeping the ionic strength constant and the actual pH values
were calculated based on the strong acid content. The recorded
UV-vis spectra were the same at pH between 2.9 and ∼8, while
significant changes of the charge-transfer band are seen at pH
> 8.5, and λmax is shifted from 376 nm up to 384 nm. In
addition, a well-isolated isosbestic point is observed at 432 nm
showing a clean transformation of the [ML] complex to
another species, most probably [ML(OH)]−. The appearance of
the isosbestic point suggests that the metal complex does not
decompose under these conditions, merely it is deprotonated.
1H NMR spectra recorded for the [Rh(η5-C5Me5)(H2O)3]2+–
HQS system at a 1 : 1 metal-to-ligand ratio at various pH values
(Fig. 2) undoubtedly reveal that neither a free metal ion nor a
ligand is present at pH > 2.9, which means that the complex
does not suﬀer from decomposition due to its outstanding
high stability at 1 mM concentration. An upfield shift of all
peaks belonging to the [ML] complex is observed in the basic
pH range due to the fast exchange process between the
aquated and the mixed hydroxido species. Therefore, pKa of
the aqua complex could be determined on the basis of the pH-
dependent chemical shift (δ) values, which is in an excellent
agreement with the data obtained spectrophotometrically,
while a somewhat lower pKa [ML] could be calculated based on
the pH-potentiometric titrations (Table 2).
As HQ, PHQ and their metal complexes have much lower
solubility in water compared to that of HQS, their complexa-
tion processes could only be studied by UV-vis spectro-
photometry using much lower concentrations (cL ∼ 50–160 μM).
The behavior of these ligands was found to be quite similar to
that of the reference compound HQS, however the complex for-
mation with HQ starts at higher pH due to the higher pKa
values, thus stronger basicity of this ligand (Fig. 3). The equili-
brium constants providing the best fits to the experimental
data are listed in Table 2.
Concentration distribution curves for the [Rh(η5-C5Me5)
(H2O)3]
2+–HQ/PHQ systems were computed on the basis of the
stability constants (Fig. 4), which represent the predominant
formation of the [Rh(η5-C5Me5)(L)(H2O)] complexes in the pH
range from 4 to 8 in both cases at the biologically more rele-
vant 50 μM concentration.
Notably, the pKa [ML] values of these Rh(η5-C5Me5) com-
plexes are rather high (∼10) and consequently the formation of
mixed hydroxido species at pH 7.4 is negligible in the absence
of chloride ions. The presence of the chloride ions generally
Fig. 1 UV–Vis spectra recorded for the [Rh(η5-C5Me5)(H2O)3]2+–HQS
(1 : 1) system at pH 0.7–1.9 (a) and pH 2.0–11.7 (b). Dashed spectrum
shows the sum of those of HQS and [Rh(η5-C5Me5)(H2O)3]2+.{cL = cRh =
160 μM; T = 25 °C; I = 0.20 M (KNO3)}.
Fig. 2 1H NMR spectra recorded for the [Rh(η5-C5Me5)(H2O)3]2+–HQS
(1 : 1) system at the indicated pH values (peak assignation: CH(2) (■), CH
(4) (●), C5Me5 (▼, ∇), empty symbol = unbound organometallic cation).
{cHQS = 1 mM; T = 25 °C; I = 0.20 M (KNO3); 10% D2O}.
Fig. 3 UV–Vis spectra recorded for the [Rh(η5-C5Me5)(H2O)3]2+–HQ
(1 : 1) system at pH 2.0– 11.5. Inset shows the absorbance values at
400 nm plotted against the pH {cL = cRh = 150 μM; T = 25 °C; I = 0.20 M
(KNO3)}.
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results in even higher pKa [ML] values,
16,17,41 therefore the
deprotonation of the [Rh(η5-C5Me5)(L)(H2O)] complexes of
8-hydroxyquinolines is not likely under physiological
conditions.
In the studied Rh(η5-C5Me5) complexes the bidentate
8-hydroxyquinoline ligands coordinate most probably via the
(N,O−) donor set, which was confirmed by X-ray crystallogra-
phy in the case of HQ (see the next section).
Crystallographic structure determination of complex
[Rh(η5-C5Me5)(8-quinolinolato)(Cl)] (1)
Single crystals of [Rh(η5-C5Me5)(8-quinolinolato)(Cl)] (1) were
obtained by the slow diﬀusion method from an ethanol/water
mixture at neutral pH and at room temperature. The crystal
structure has been determined by single crystal X-ray diﬀrac-
tion, crystal data and structure refinement parameters are seen
in Table S1.† The ORTEP representation of the complex is
depicted in Fig. 5a, while the packing arrangement is shown
in Fig. S3.† Selected bond distances and angles are collected
and given in comparison to the analogous iridium(III)
complex22 in Table 3. The complex [Rh(η5-C5Me5)(8-quinolino-
lato)(Cl)] crystallized in the monoclinic crystal system, in the
space group Cc with three water molecules in the asymmetric
unit.
As it is expected, the rhodium(III) center exhibits a pseudo-
octahedral (“piano-stool”) geometry, and the C5Me5 moiety
occupies facially three coordination sites, while the deproto-
nated ligand is bidentate via its (N,O) donors and the coordi-
nation sphere is completed with a chlorido ligand. The
binding of the diﬀerent donor groups resulted in a pseudo-
chiral center for Rh, notwithstanding the complex crystallized
in a racemic form. The measured Rh–N and Rh–Cl bond
lengths were found to be very similar to the reported values for
this complex based on DFT calculations (Rh–N: 2.115 Å,
Rh–Cl: 2.416(2) Å).19 On the other hand the measured Rh–O
bond length is somewhat longer, while the Rh-ring centroid
distance is significantly shorter than the calculated values
(Rh–O: 2.065 Å, Rh–ring centroid: 1.887 Å).19 The molecular
structure of the complex was compared directly with that of
[Ir(η5-C5Me5)(quinolin-8-olate)(Cl)] (Fig. 5b), which crystallized
without solvate inclusion in the orthorhombic Pna21 space
group (unit cell dimensions are a = 15.285(3), b = 8.335(2), c =
13.626(3) Å).22
The metal ion–C5Me5 ring centroid distance is very similar
for the two complexes (1.768(3) Å in rhodium(III) and 1.789(5) Å
in iridium(III) species, respectively); however the angles
between the pentamethylcyclopentadienyl (A) and the 8-quino-
linolato rings (B, C) diﬀer significantly (Table 3 and Fig. 5b).
The diﬀerence between the structures of these organorhodium
and organoiridium complexes can be due to dissimilar
Fig. 5 Molecular structure of the metal complex [Rh(η5-C5Me5)
(8-quinolinolato)(Cl)] (1) with the indication of rings (A–C). Displacement
parameters are drawn at 50% probability level and solvent molecules
and hydrogens are omitted for clarity (a). Comparison of the molecular
structure of complex 1 (colored by element) with [Ir(η5-C5Me5)(8-quino-
linolato)(Cl)] (CSD ref. code VUMQAW) (rose)22 (b).
Table 3 Selected bond distances (Å) and angles (°) of the metal com-
plexes [Rh(η5-C5Me5)(8-quinolinolato)(Cl)] (1) and [Ir(η5-C5Me5)(8-quino-
linolato)(Cl)] (VUMQAW22)
M = Rh (1) M = Ir (VUMQAW)22
Bond length (Å)
M–Cl1 2.417(2) 2.386(2)
M–O1 2.099(4) 2.091(6)
M–N1 2.116(5) 2.088(7)
M–C1 2.165(5) 2.163(12)
M–C2 2.144(5) 2.135(13)
M–C3 2.140(6) 2.155(9)
M–C4 2.139(6) 2.177(9)
M–C5 2.160(6) 2.164(10)
M–Cg(A)a 1.768(3) 1.789(5)
M–Cg(BC)a 2.139(6) 2.177(9)
Bond angles (°)
O1–M–N1 78.4(2) 77.8(3)
O1–M–Cl1 86.5(1) 84.6(2)
N1–M–Cl1 90.7(1) 85.2(2)
Cg(A)–M–O1a 127.85(12) 131.2(2)
Cg(A)–M–N1a 130.73(15) 133.2(2)
Cg(A)–M–Cl1a 126.74(9) 126.8(2)
Cg(A)–Cg(BC)b 49.0(3) 60.9(5)
a Cg is the center of gravity calculated for rings A or BC. b Angles
between planes calculated for the rings A and BC.
Fig. 4 Concentration distribution curves for the [Rh(η5-C5Me5)
(H2O)3]
2+–HQ (black lines) and [Rh(η5-C5Me5)(H2O)3]2+–PHQ (grey lines)
(1 : 1) systems calculated on the basis of the stability constants deter-
mined {cRh = cL = 50 μM; T = 25 °C; I = 0.20 M (KNO3); n = 1 (HQ),
2 (PHQ)}.
Paper Dalton Transactions
4386 | Dalton Trans., 2017, 46, 4382–4396 This journal is © The Royal Society of Chemistry 2017
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
M
ar
ch
 2
01
7.
 D
ow
nl
oa
de
d 
on
 7
/3
/2
01
9 
6:
09
:2
1 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
secondary interactions with neighbouring molecules as
diﬀerent molecular arrangements and solvate inclusion rea-
lized in the two kinds of crystal structures. In the crystal lattice
of the rhodium(III) complex the molecules are packed in a way
that channels are formed (Fig. 6). The volume of the solvent
accessible voids are 157 Å3 calculated by using program
PLATON.42 Selected secondary interactions are shown in
Fig. S4,† and the collection of the main intermolecular inter-
actions is listed in Table S2.† It is worth mentioning that the
isolated [Rh(η5-C5Me5)(L)(Cl)] complex was also characterized
in this work by 1H NMR spectroscopy and electrospray ioni-
zation mass spectrometry, confirming the coordination of the
ligand to the metal center.
Complex formation equilibria of [Ru(η6-p-cymene)(H2O)3]2+
with HQ, HQS and PHQ
The complex formation of [Ru(η6-p-cymene)(H2O)3]2+ with the
chosen 8-hydroxyquinoline ligands is a rather slow process
compared to the case of the Rh(η5-C5Me5) species due to the
markedly increased trans eﬀect of the anionic pentamethyl-
cyclopentadienyl ligand in comparison to the neutral arene
ligand. For example the equilibrium could be reached after
more than 120 min in the [Ru(η6-p-cymene)(H2O)3]2+–HQS
system at pH 3 as the time-dependence of the UV-vis spectra
indicates (Fig. S5†), which hindered the application of conven-
tional pH-potentiometric titrations. To overcome this problem,
individual samples were prepared by the addition of diﬀerent
amounts of strong base under Ar, and the actual pH and the
UV-vis and/or 1H NMR spectra were measured after 24 h.
Besides the altered complexation kinetics of the organo-
rhodium and organoruthenium compounds with the 8-hydro-
xyquinolines, the other most conspicuous diﬀerence is that
the organoruthenium cation starts to form complexes at much
lower pH values. As a consequence log K [ML] constants were
determined from the UV-vis spectral changes in the pH range
from 0.7 to 3.0 for the HQ and PHQ complexes (Table 2).
Although, the spectra recorded at pH 0.7 and 3 for the [Ru(η6-
p-cymene)(H2O)3]
2+–HQS were almost identical due to the neg-
ligible decomposition of the complex under the strongly acidic
conditions. Therefore the stability constant could not be
obtained based on these UV-vis spectra. Only a lower limit for
the log K [ML] stability constant (Table 2) could be estimated
from the 1H NMR spectrum recorded at pH 0.7 at a 1 : 1 metal-
to-ligand ratio based on the integrated peak areas of the iso-
propyl methyl protons of the p-cymene ring belonging to the
bound and unbound fractions of the organometallic fragment.
In the [Ru(η6-p-cymene)(L)(H2O)] complexes in solution the
ligand coordinates most probably in the same bidentate
manner via the (N,O−) donors as in the case of the analogous
rhodium(III) species (vide supra) and as the crystal structures
reported for both [Ru(η6-p-cymene)(8-quinolinolato)(Cl)]23 and
[Ru(η6-p-cymene)(8-quinolinolato)(H2O)]+ (ref. 24) complexes
also show. Deprotonation of the coordinated water molecule in
the [Ru(η6-p-cymene)(L)(H2O)] species was characterized by the
pKa [ML] values determined by the deconvolution of the
1H
NMR (only in the case of HQS) and UV-vis spectra (Table 2).
pH-Dependent 1H NMR spectra in a 10% DMSO/D2O mixture
were also reported for the [Ru(η6-p-cymene)(L)Cl] complex of
HQ, however no time-dependent measurements were per-
formed and no pKa [ML] was provided.
21 It is noteworthy that
the log K [ML] values are higher, while pKa [ML] constants are
lower by ca. 1–1.5 orders of magnitude obtained for the Ru(η6-
p-cymene) complexes compared to the those of the Rh(η5-
C5Me5) counterparts. Based on these values it can be predicted
that the deprotonation of the Ru(η6-p-cymene) complex formed
with HQS, where pKa [ML] is the lowest among the studied
complexes, takes place still to a low extent at physiological pH.
(Formation of ca. 7% [ML(OH)] is estimated in the chloride-
free medium at 50 μM concentration of the monocomplex in
this particular case.)
In the presence of ligand excess novel bands appeared
unexpectedly in the UV-vis spectra recorded for the [Ru(η6-p-
cymene)(H2O)3]
2+–HQS (1 : 2) system at pH 7.4 (Fig. 7). As the
complex formation is slow, it was expected that the final spec-
trum is the sum of those of the [Ru(η6-p-cymene)(L)(H2O)]
monocomplex and one equivalent unbound ligand (see the red
dashed lines in Fig. 7). In addition, the development of these
new bands depends on the conditions, namely diﬀerent spec-
tral changes were observed under aerobic conditions or under
an Ar atmosphere. The solution turned green with time in the
presence of O2 (λmax ∼ 406 nm), on the contrary when Ar was
bubbled though the sample it became reddish (λmax ∼ 530 and
406 nm). It should be noted that in the case of the Ar atmo-
sphere the presence of minor O2 was possible. The absorbance
values at both wavelength maxima become much higher with
time than it is expected (see the inset of Fig. 7a). The band at
406 nm most probably appears as a consequence of O2, as the
absorbance increased significantly when O2 gas was purged
through the samples kept under Ar previously, while the band
at 530 nm was decreased (Fig. S6†).
Additionally, the 1H NMR spectrum recorded at a
1 : 2 metal-to-ligand ratio (in air) at pH 7.4 showed intense
broadening of the signals. All these findings strongly suggest
Fig. 6 Packing arrangement showing water channels viewing along the
c crystallographic axis in crystal [Rh(η5-C5Me5)(8-quinolinolato)(Cl)] (1).
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that HQS is able to replace the arene ring at least partially, and
this process sensitizes ruthenium(II) to oxidation. In order to
confirm the formation of ruthenium(III) in the [Ru(η6-p-
cymene)(H2O)3]
2+–HQS system, EPR spectra were recorded at
pH 7.4 and at 11.1 as well at ligand excess (Fig. S7†). The EPR
spectra undoubtedly show that the oxidation of the ruthenium
center took place indeed at both pH values. The appearance of
ruthenium(III) was also seen in the case of HQ (Fig. S8†). The
partial loss of the arene ligand was reported for [Ru(η6-
biphenyl)(L)Cl] complexes where L = 2,2′-bipyridine or 3,3′-
hydroxy-2,2′-bipyridine during aquation, however the report
does not indicate the pH-range for the process.43 On the other
hand, the co-incubation of the [Ru(η6-p-cymene)(8-quinolino-
lato)Cl] complex with cysteine, that has a strong binding
aﬃnity towards Ru(η6-p-cymene), led to the quick release of
the arene moiety and degradation of the complex.21
Comparison of the solution stability of the studied
organometallic complexes
In order to compare the solution stability of the Ru(η6-p-
cymene) and Rh(η5-C5Me5) complexes formed with the
8-hydroxyquinoline ligands HQ, PHQ and HQS there are
several possibilities. However, the direct comparison of the
determined log K [ML] values (Table 2) is not adequate, since
the complex formation equilibrium is superimposed by other
accompanying equilibria, such as (de)protonation of the
ligands and hydrolysis of the organometallic cations.
Conditional stability constants (log K′ [ML]) taking into con-
sideration the diﬀerent basicities of the ligands can be com-
puted at a fixed pH value or as a function of pH.44 Thus log K′
[ML] values were calculated at pH 7.4 (Fig. 8a) for the com-
plexes of the studied 8-hydroxyquinolines, which give the fol-
lowing order: HQS > HQ > PHQ in the case of both organo-
metallic cations.
Another option is the calculation of pM values for a particu-
lar ligand. Basically pM is the negative logarithm of the equili-
brium concentration of the unbound metal ion, and a higher
pM value indicates a stronger metal ion binding ability of the
ligand under given circumstances. The tendency of these
organometallic fragments to hydrolyze shows remarkable
diﬀerences, which has to be taken into account for a more ade-
quate comparison of the complex stabilities. Namely, the
hydrolysis of the [Ru(η6-p-cymene)(H2O)3]2+ cation is stronger
and occurs at lower pH values compared to [Rh(η5-C5Me5)
(H2O)3]
2+,16,36 thus the extent of competition between a given
ligand and the hydroxide ion for the metal is diﬀerent as
well. Therefore the formation of the various hydroxido species
([(Rh(η5-C5Me5))2(μ-OH)3]+, [(Rh(η5-C5Me5))2(μ-OH)2]2+ and
Fig. 7 Time-dependent UV–vis absorbance spectra of the [Ru(η6-p-
cymene)(H2O)3]
2+–HQS (1 : 2) system at pH 7.4 under aerobic conditions
(a) and under an Ar atmosphere (b); red dashed spectrum is calculated
as sum of those of [Ru(η6-p-cymene)(HQS)(H2O)] and 1 eq. HQS. Inset
(in a) shows the time-dependent changes of absorbance at 406 nm and
530 nm, the symbol colors correspond to the spectrum coloring {cRu =
223 μM; cHQS = 444 μM; pH = 7.4 (20 mM phosphate buﬀer); T = 25 °C}.
Fig. 8 Conditional stability constants (log K’ [ML]) of [Rh(η5-C5Me5)(L)(H2O)] (black bars) and [Ru(η6-p-cymene)(L)(H2O)] (grey bars) complexes of
HQS, HQ and PHQ at pH 7.4. K’ [ML] = K [ML]/αH, where αH ¼ 1þ
P
i
½Hi  βðHiLÞ. {T = 25 °C; I = 0.20 M (KNO3)} (a). pM* values at pH 7.4, where
pM* = −log([M] + [M2(OH)3] + [M2(OH)2]) {cM = 50 μM; M : L = 1 : 1; T = 25 °C; I = 0.20 M (KNO3)} (b).
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[(Ru(η6-p-cymene)2(μ-OH)3]+), which are all unbound forms of
the metal ions besides the triaqua species, should be con-
sidered and pM* values (pM* = −log([M] + [M2(OH)3] +
[M2(OH)2])) were computed at pH 7.4 using the experimentally
determined stability constants instead of the simple pM
(Fig. 8b). pM* values are shown in the pH range from 2 to 10.5
for complexes of HQ in Fig. S9.†
The pM*7:4 values show the same trend of the metal binding
eﬀectiveness of the investigated ligands as the conditional
stability constants (Fig. 8a), although they are always higher
for the Rh(η5-C5Me5) complexes due to the higher aﬃnity of
Ru(η6-p-cymene) towards the hydroxide ions diminishing the
ligand-bound fractions. It is worth mentioning that these
pM*7:4 values indicate the formation of very high stability com-
plexes, even in the case of the lowest value (Ru(η6-p-cymene)
complex of PHQ) decomposition of less than 1% is estimated
at 50 μM concentration. The predominant species at pH 7.4 is
the [ML] type complex in all cases. These findings suggest that
the studied organometallic complexes are able to retain their
bidentate 8-hydroxyquinoline ligand in the coordination
sphere under physiological conditions (at pH 7.4, biologically
relevant low concentrations) and merely substitution of the
aqua ligand by chloride (or vice versa) or by donor atoms of
bioligands such as proteins in the biofluids is probable.
Chloride ion aﬃnity and lipophilicity of the studied
organometallic complexes
In most of the half-sandwich Ru(η6-p-cymene) and Rh(η5-
C5Me5) complexes of bidentate ligands a chloride ion is co-
ordinated as a leaving group in the solid forms. Aquation (Cl−/
H2O exchange) followed by dissolution in aqueous solution is
known to be an important step of mechanism of activation for
many anticancer drugs such as cisplatin,45 and has a key role
in the DNA/protein interactions. In the case of Ru(η6-arene)
complexes it is also assumed that the aqua complex [Ru(η6-
arene)(L)H2O] is responsible for the bioactivity, therefore the
exchange of the chlorido ligand to water should occur with
adequate rate and extent.46 The hydrolysis of the M–Cl bond
was found to be fairly fast for the studied 8-hydroxyquinoline
complexes, the equilibrium could be reached within some
minutes. The immediate formation of the aqua species from
the [Ru(η6-p-cymene)(8-quinolinolato)Cl] complex was reported
by Kubanik et al.21 in conjunction with our findings. In our
experimental setup the following equilibrium process was
studied spectrophotometrically: [M(L)(H2O)] + Cl
− ⇌ [M(L)(Cl)]
+ H2O. The displacement of water by the chlorido ligand
results in characteristic spectral changes in the UV-vis spectra
as Fig. 9 shows for the Rh(η5-C5Me5) complex of HQS. Namely,
λmax is increased with increasing absorbance upon higher
chloride ion concentrations at pH 7.4.
Equilibrium constants (see log K′ (H2O/Cl
−) values in
Table 2) and the individual spectra of the aquated and chlori-
nated complexes could be estimated by the deconvolution of
the measured spectra (see the inset in Fig. 9). The equilibrium
constants of the Ru(η6-p-cymene) complexes are more than
one order of magnitude lower compared to those of the Rh(η5-
C5Me5), reflecting a significantly lower aﬃnity of these ruthe-
nium(II) species towards the chloride ion and an easier replace-
ment by water or by donor atoms of biomolecules. The ratio of
the aquated and chlorinated species depends on the actual
concentration of the chloride ions. The distribution of these
species was estimated for the HQ complexes based on the
determined log K′ (H2O/Cl
−) constants at 100, 24 and 4 mM
chloride content in accordance with the blood serum, cell
plasma and cell nucleus,45 respectively (Fig. 10). It can be con-
cluded that the extent of aquation is higher for the Ru(η6-p-
cymene) complexes, and it is assumed that 97% and 80% of
the organoruthenium and the organorhodium complexes
respectively are present in solution as the more reactive aqua
species at 4 mM chloride ion concentration.
Fig. 10 Estimated distribution (%) of the aqua (ﬁlled bars) and chlorido
(empty bars) complexes of HQ formed with Rh(η5-C5Me5) (black) and
Ru(η6-p-cymene) (grey) at 100, 24 and 4 mM concentration of chloride
ions calculated on the basis of the exchange constants (log K’ (H2O/Cl
−))
{cL = cM = 100 μM; pH = 7.40; T = 25 °C}.
Fig. 9 Measured (●) and ﬁtted (dotted line) absorbance values at
384 nm at various chloride ion concentrations in the [Rh(η5-C5Me5)
(H2O)3]
2+–HQS (1 : 1) system at pH 7.4. Inset shows the individual calcu-
lated molar absorbance spectra of [Rh(η5-C5Me5)(L)(H2O)] (grey spec-
trum) and [Rh(η5-C5Me5)(L)(Cl)]− (black spectrum) {cL = cRh = 160 μM;
cCl− = 0–0.08 M; T = 25 °C}.
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The dependence of cytotoxicity on chloride ion aﬃnity has
been reported for several Ru(η6-arene) complexes47 as well as
for a series of Rh(η5-C5Me5) compounds.41 However, besides
the chloride aﬃnity the lipophilicity is another crucial factor
determining the antiproliferative activity as it influences the
solubility and the passage through the cell membrane.
Lipophilicity of the half-sandwich organometallic com-
plexes is not only governed by the lipophilic character of the
coordinated ligand and the arene/arenyl moiety, but the chlor-
ide/water exchange also has an impact on the lipophilic char-
acter as it alters the net charge of the complexes. Therefore,
distribution coeﬃcients at pH 7.4 (logD7.4) were determined
for the complexes of HQ and PHQ at various chloride ion con-
centrations (Table 4). logD7.4 values for the ligands and the
organometallic cations are also shown for comparison, but the
data were not determined for the HQS complexes as they were
found to be non-cytotoxic (IC50 > 100 μM in the cell lines
studied, see the next section) most likely due to their much
stronger hydrophilic character. A calculated log P value of
+0.46 was reported for the complex [Ru(η6-p-cymene)(8-quinoli-
nolato)Cl],21 but the possible Cl−/H2O exchange was not taken
into consideration. Based on the data in Table 4 it can be con-
cluded that the HQ complexes are more lipophilic than the
PHQ species similarly to the case of the metal-free ligands.
The lower log D7.4 value of PHQ is a consequence of the proto-
nated piperidinium moiety. On the other hand the general
trend for the increasing lipophilicity of the metal complexes is
observed with increasing chloride ion concentration as the
compounds become more chlorinated, thus the net charge
turns to be lower (e.g. [M(L)(H2O)]
+ → [M(L)(Cl)] in the case of
HQ complexes). In the absence of chloride ions both the
triaqua and the mono-ligand aqua complexes are more lipo-
philic in the case of the Ru(η6-p-cymene), however the logD7.4
values are higher for the Rh(η5-C5Me5) complexes of HQ, PHQ
when chloride ions are present in the solution, thus in the
coordination sphere.
Consequently, the lipophilicity of these organometallic
complexes shows a strong dependence on the actual chloride
ion concentration.
Cytotoxic activity and MDR-selective activity in cancer cell lines
The cytotoxic eﬀect of ligand HQ and its Ru(η6-p-cymene) and
Rh(η5-C5Me5) complexes measured in various cancer cell lines
has been already reported. A recent study of Kubanik el al. pro-
vides IC50 values of 1.97–5.96 μM for HQ and 11.4–19.3 μM for
[Ru(η6-p-cymene)(8-quinolinolato)Cl] in human colorectal
(HCT116), non-small cell lung (NCI-H460), and cervical carci-
noma (SiHa) cells.21 The metal complex showed good activity
that is clearly associated with the cytotoxic activity of the
ligand. Similar IC50 values were obtained for this ruthenium(II)
complex in ovarian (CH1) and colon carcinoma (SW480) cell
lines.20 The [Rh(η5-C5Me5)(8-quinolinolato)Cl] complex was
found to be active in human melanoma and glioblastoma cells
(IC50 ∼ 0.8–100 μM) and showed good activity against Gram-
positive bacteria as well.19 The piperidine derivative of HQ
(PHQ) is also a cytotoxic compound and has a strong prefer-
ence for targeting MDR cell lines, while HQ does not exert
MDR-selectivity.29
Here, our aim was to reveal whether the complexation of
PHQ with the studied organometallic cations resulting in the
formation of very high stability complexes can modify the
intrinsic cytotoxic eﬀectiveness and the MDR-selectivity of the
ligand.
The cytotoxic activity of PHQ, HQ and HQS was investigated
in the absence and in the presence of one equivalent of
[Ru(η6-p-cymene)(H2O)3]2+ or [Rh(η5-C5Me5)(H2O)3]2+ cations in
MES-SA (human uterine sarcoma) and in its multidrug-resist-
ant counterpart (MES-SA/Dx5) cell lines by means of the colori-
metric 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT) assay, as detailed in the Experimental section.
The resistance of MES-SA/Dx5 cells is primarily mediated by
the overexpression of P-gp, a member of the ABC transporter
family, which pumps out xenobiotics from the cells. P-gp
expression is significantly increased in multidrug-resistant
tumor cells resulting in decreased intracellular drug accumu-
lation. In order to show the eﬀect of the active pump, experi-
ments were also performed in the presence of the P-gp-inhibi-
tor Tariquidar (TQ), which binds with high aﬃnity to the P-gp
transporter. The clinical drug and the P-gp substrate doxo-
rubicin was used as a positive control. As a further control, the
cytotoxicity of the organometallic cations was measured as
well.
The IC50 values are collected in Table 5. Notably, the toxicity
of the organometallic cations and the HQS containing samples
is negligible. The cytotoxicity of the ligands HQ and PHQ in
MES-SA cell lines is very similar, and both are more active in
Table 4 n-Octanol/water distribution coeﬃcients at pH 7.4 (logD7.4) for the [Rh(η5-C5Me5)(L)(Z)] and [Ru(η6-p-cymene)(L)(Z)] (Z = H2O/Cl−;
charges are omitted for clarity) complexes formed with HQ and PHQ as well as the corresponding free ligands and organometallic precursors for
comparison at various chloride ion concentrations {T = 25 °C, pH = 7.4 (20 mM phosphate buﬀer)a
logD7.4
Rh(η5-C5Me5) Ru(η6-p-cymene)
ligand alone
cCl− = 0.0 M 0.1 M 0.5 M 0.0 M 0.1 M 0.5 M 0.1 M
HQ −0.63(2) +0.75(3) +0.80(1) +0.10(1) +0.54(1) +0.78(8) +1.81(2)b
PHQ −1.22(4) −0.55(1) −0.31(1) −1.05(1) −0.78(1) −0.59(1) +0.93(4)
No ligand <−2.00c −0.61c −0.46c −1.71(2) −0.46(2) +0.33(8) —
aUncertainties (SD) of the last digits are shown in parentheses. b logD7.4 = +1.78.
48 cData are taken from ref. 18.
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MES-SA/Dx5 cells, however the selectivity ratio, i.e. IC50
(MES-SA)/IC50 (MES-SA/Dx5), is much higher for PHQ that is
considered as a MDR selective compound.29 For a better com-
parison of the biological data the pIC50 values obtained in the
MES-SA/Dx5 cells are plotted against those of the MES-SA cells
(Fig. 11a and b) and the selectivity ratio is also shown for the
ligands and the metal complexes (Fig. 11c).
The selectivity ratio is an indicator of the increased sensi-
tivity of the MDR MES-SA/Dx5 cell line as compared to the par-
ental MES-SA cell line. A selectivity ratio >2 indicates that
MES-SA/Dx5 cells are paradoxically more sensitive, rather than
more resistant, to a given compound. It is important to note
that collateral sensitivity may be limited to a particular cell
line.30,49 To establish the requirement of functional P-gp, we
repeated the cytotoxicity experiments in the presence of the
P-gp-inhibitor TQ. As expected, TQ has no impact on the IC50
values of all the studied compounds in the case of the P-gp
negative parental MES-SA cells. In contrast, by inhibition of
the transporter, MES-SA/Dx5 cells become more sensitive to
the P-gp substrate doxorubicin. The cytotoxicity of the ligand
HQ and its complexes is independent of the presence of TQ in
the MES-SA/Dx5 cell lines. On the contrary, higher IC50 values
were observed for the ligand PHQ and its Rh(η5-C5Me5)
complex in MES-SA/Dx5 cells when TQ was added to the
samples, proving that the cytotoxicity is indeed potentiated by
P-gp. The IC50 values obtained for Ru(η6-p-cymene) and Rh(η5-
C5Me5) complexes of HQ and PHQ are similar to those of the
free ligands, although the values are somewhat higher in the
case of the Ru(η6-p-cymene) complexes in MES-SA and
MES-SA/Dx5 cells. As a consequence, the selectivity ratio
remained low and unaﬀected by the complexation in the case
of the non-MDR selective compound HQ (Fig. 11c). The selecti-
vity ratio calculated for PHQ and its Rh(η5-C5Me5) complex is
fairly high, while the complex formation with Ru(η6-p-cymene)
seems to abolish MDR selective activity. The altered behavior
of the Ru(η6-p-cymene) and Rh(η5-C5Me5) complexes of PHQ
most likely cannot be explained simply on the basis of the
solution speciation data and their lipophilic character, which
shows dependence on the chloride ion concentration. Both
complexes possess undoubtedly high stability, whereas their
decomposition is assumed to be negligible in solution under
physiological conditions. On the other hand, the Ru(η6-p-
cymene) complex is kinetically more inert, it has somewhat
lower chloride-aﬃnity, thus more double positively charged
mono-aqua [Ru(η6-p-cymene)(L)(H2O)]2+ species are present in
the solution, and the complex has slightly more hydrophilic
character in the medium containing chloride ions at concen-
tration ≤100 mM. These features can aﬀect the biological
activity; however other factors such as the 3D structure, or the
interaction with bioligands might also be relevant.
Experimental
Chemicals
All solvents were of analytical grade and used without further
purification. HQ, HQS, [Rh(η5-C5Me5)(μ-Cl)Cl]2, [Ru(η6-p-
cymene)(μ-Cl)Cl]2, KCl, KNO3, AgNO3, HCl, HNO3, KOH, 4,4-
dimethyl-4-silapentane-1-sulfonic acid (DSS), dimethyl sulfox-
ide (DMSO), NaH2PO4 and Na2HPO4 were purchased from
Sigma-Aldrich in puriss quality. The ligand PHQ (NSC57969)
was acquired from the drug repository of the Developmental
Therapeutics Program of the National Cancer Institute. Doubly
distilled Milli-Q water was used for sample preparation. The
exact concentration of the ligand stock solutions together with
the proton dissociation constants were determined by pH-
potentiometric titrations with the use of the computer
program HYPERQUAD.50 The aqueous [Rh(η5-C5Me5)(H2O)3]
(NO3)2 and [Ru(η6-p-cymene)(H2O)3](NO3)2 stock solutions
were obtained by dissolving the exact amounts of [Rh(η5-
C5Me5)(μ-Cl)Cl]2 or [Ru(η6-p-cymene)(μ-Cl)Cl]2 respectively in
water followed by the removal of chloride ions by the addition
of equivalent amounts of AgNO3. The exact concentrations of
[Rh(η5-C5Me5)(H2O)3]2+ and [Ru(η6-p-cymene)(H2O)3]2+ were
Table 5 In vitro cytotoxicity (IC50 values in μM) of the [Rh(η5-C5Me5)(L)(Z)] and [Ru(η6-p-cymene)(L)(Z)] (Z = H2O/Cl−; charges are omitted for
clarity) complexes formed with HQ, HQS and PHQ as well as the corresponding free ligands, organometallic precursors and doxorubicin for com-
parison in two human cancer cell lines in the presence or absence of TQ (72 h exposure)
IC50/μM MES-SA MES-SA/Dx5 MES-SA + 1 μM TQ MES-SA/Dx5 + 1 μM TQ
Doxorubicin 0.087 ± 0.022 3.1 ± 1.1 0.064 ± 0.013 0.036 ± 0.008
[Ru(η6-p-cymene)(Z)3] >100 >100 >100 >100
[Rh(η5-C5Me5)(Z)3] >100 >100 >100 >100
HQ Ligand 3.3 ± 1.1 1.08 ± 0.26 3.7 ± 1.3 1.28 ± 0.07
[Ru(η6-p-cymene)(L)(Z)] 13.1 ± 4.1 3.57 ± 0.61 11.87 ± 0.27 4.6 ± 1.1
[Rh(η5-C5Me5)(L)(Z)] 3.57 ± 0.93 2.03 ± 0.27 4.24 ± 0.24 2.00 ± 0.25
PHQ Ligand 3.63 ± 0.58 0.62 ± 0.03 3.46 ± 0.02 3.75 ± 0.51
[Ru(η6-p-cymene)(L)(Z)] 5.25 ± 0.88 19.8 ± 5.4 5.54 ± 0.70 66 ± 33
[Rh(η5-C5Me5)(L)(Z)] 4.63 ± 0.35 0.90 ± 0.12 4.75 ± 0.07 4.41 ± 0.41
HQS Ligand >100 >100 >100 >100
[Ru(η6-p-cymene)(L)(Z)] >100 >100 >100 >100
[Rh(η5-C5Me5)(L)(Z)] >100 >100 >100 >100
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determined by pH-potentiometric titrations employing stabi-
lity constants for [(Rh(η5-C5Me5))2(μ-OH)i](4−i)+ (i = 2 or 3)16
and [(Ru(η6-p-cymene))2(μ-OH)3]+ (ref. 37) complexes,
respectively.
pH-Potentiometric measurements
pH-Potentiometric measurements determining proton dis-
sociation constants of ligands HQ and HQS and overall stabi-
lity constants for tested Rh(η5-C5Me5)–HQS complexes were
carried out at 25.0 ± 0.1 °C in water and at a constant ionic
strength of 0.20 M KNO3. The titrations were performed in a
carbonate-free KOH solution (0.20 M). The exact concen-
trations of HNO3 and KOH solutions were determined by pH-
potentiometric titrations. An Orion 710A pH-meter equipped
with a Metrohm “double junction” combined electrode (type
6.0255.100) and a Metrohm 665 Dosimat burette were used for
the pH-potentiometric measurements. The electrode system
was calibrated to the pH = −log[H+] scale by means of blank
titrations (strong acid vs. strong base: HNO3 vs. KOH), as
suggested by Irving et al.51 The average water ionization con-
stant, pKw, was determined as 13.76 ± 0.01 at 25.0 °C, I =
0.20 M (KNO3), which is in accordance with the literature.
52
The reproducibility of the titration points included in the
calculations was within 0.005 pH units. The pH-potentiometric
titrations were performed in the pH range between 2.0 and
11.5. The initial volume of the samples was 10.0 mL. The
ligand concentration was 1.0 mM and was investigated at
metal ion-to-ligand ratios of 1 : 1, 1 : 1.5, and 1 : 2. The
accepted fitting between the measured and calculated titration
data points regarding the volume of the titrant was <10 μL.
The samples were degassed by bubbling purified argon
through them for about 10 minutes prior to the measurements
and the inert gas was also passed over the solutions during the
titrations.
The computer program PSEQUAD53 was utilized to estab-
lish the stoichiometry of the complexes and to calculate the
overall stability constants. β(MpLqHr) is defined for the general
equilibrium: pM + qL + rH ⇌ MpLqHr as β(MpLqHr) = [MpLqHr]/
[M]p[L]q[H]r; where M denotes the metal moiety [Rh(η5-C5Me5)
(H2O)3]
2+ or [Ru(η6-p-cymene)(H2O)3]2+ and L the completely
deprotonated ligand. β values for the various hydroxido com-
plexes [(Rh(η5-C5Me5))2(μ-OH)i](4−i)+ (i = 2 or i = 3) or [(Ru(η6-p-
cymene))2(μ-OH)3]+ were calculated based on the pH-potentio-
metric titration data in the absence of chloride ions and were
found to be in good agreement with our previously published
data.16,37
Fig. 11 pIC50 (= −log(IC50 expressed in M)) values measured in MES-SA/Dx5 cells of the ligand HQ (a) and PHQ (b) with their Rh(η5-C5Me5) and
Ru(η6-p-cymene) complexes plotted against those obtained in MES-SA cells in the absence (ﬁlled symbols) or in the presence (empty symbols) of
TQ. Symbols: ligand alone (◆), Rh(η5-C5Me5) complexes (●), Ru(η6-p-cymene) complexes (▲). The selectivity ratio (IC50 (MES-SA)/IC50 (MES-SA/
Dx5)) for ligands (Lig: HQ, PHQ) and their Ru(η6-p-cymene) (Ru) and Rh(η5-C5Me5) (Rh) complexes in the absence (left darker bars) or in the presence
(right lighter bars) of TQ (c).
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UV–vis spectrophotometric, 1H NMR EPR and ESI-MS
measurements
A Hewlett Packard 8452A diode array spectrophotometer was
used to record the UV-vis spectra in the interval 200–800 nm.
The path length was 1 or 0.2 cm. Equilibrium constants
(proton dissociation, stability constants and H2O/Cl
− exchange
constants) and the individual spectra of the species were calcu-
lated with the computer program PSEQUAD.53 The spectro-
photometric titrations were performed in pure water on the
samples containing the ligands with or without the organo-
metallic cations and the concentration of the ligands was
150–200 μM or 1 mM (HQ and HQS) and 75 μM (PHQ). The
organometallic cations were also titrated (200 μM). The metal-
to-ligand ratios were 1 : 1 and 1 : 2 in the pH range from 2 to
11.5 at 25.0 ± 0.1 °C at an ionic strength of 0.20 M (KNO3).
Measurements for 1 : 1 metal-to-ligand systems were also
carried out by preparing individual samples in which KNO3
was partially or completely replaced by HNO3 and pH values,
varying in the range ca. 0.7–2.0, were calculated from the
strong acid content. In the case of the Ru(η6-p-cymene) com-
plexes the absorbance data were always recorded after 24 h of
incubation. UV-Vis spectra were used to investigate the H2O/
Cl− exchange processes of complexes [Rh(η5-C5Me5)(L)(H2O)]
and [Ru(η6-p-cymene)(L)(H2O)] at 120–160 μM (HQ, HQS) or
50 μM (PHQ) concentration and at pH 7.40 (using 20 mM
phosphate buﬀer) as a function of chloride concentrations
(0–330 mM).
1H NMR studies were carried out on a Bruker Ultrashield
500 Plus instrument. All 1H NMR spectra were recorded with
the WATERGATE water suppression pulse scheme using a DSS
internal standard. The ligand HQS was dissolved in a 10% (v/v)
D2O/H2O mixture to yield a concentration of 1 mM and were
titrated at 25 °C, at I = 0.20 M (KNO3) in the absence or pres-
ence of [Rh(η5-C5Me5)(H2O)3]2+ at a 1 : 1 metal-to-ligand ratio
in the pH range between 2.0 and 11.5. 1H NMR spectra were
recorded on samples containing [Ru(η6-p-cymene)(H2O)3]2+
and HQS at a 1 : 2 ratio after 24 h of incubation. Stability con-
stants for the complexes were calculated by the computer
program PSEQUAD.53
All continuous-wave (CW) EPR spectra were recorded with a
BRUKER EleXsys E500 spectrometer (microwave frequency 9.81
GHz, microwave power 10 MW, modulation amplitude 5 G,
modulation frequency 100 kHz). EPR spectra were recorded at
10.0 mM of [Ru(η6-p-cymene)(H2O)3]2+ and the metal-to-HQS
ratios were 1 : 1 and 1 : 2 at pH 7.4 and 11.1.
Electrospray ionization mass spectrometric (ESI-MS)
measurements were performed using a Micromass Q-TOF
Premier (Waters MS Technologies) mass spectrometer
equipped with an electrospray ion source.
Determination of the distribution coeﬃcients
Distribution coeﬃcient (D7.4) values of the [Ru(η6-p-cymene)(L)
(Z)] and [Rh(η5-C5Me5)(L)(Z)] complexes (where L = deproto-
nated HQ or PHQ; Z = H2O/Cl
−, charges are omitted for simpli-
city) and the ligands as well as the organoruthenium Ru(η6-p-
cymene) fragment were determined by the traditional shake-
flask method in n-octanol/buﬀered aqueous solution at pH
7.40 (20 mM phosphate buﬀer) at various KCl concentrations
(cKCl = 0.0, 0.10, 0.50 M) at 25.0 ± 0.2 °C as described pre-
viously.54 The data for the organorhodium Rh(η5-C5Me5) frag-
ment were already published under similar conditions.18 Two
parallel experiments were performed for each sample. The
complexes or ligands were dissolved in n-octanol pre-saturated
aqueous solution of the buﬀer at 200 μM (HQ and HQS com-
plexes) or 75 μM (PHQ complexes) concentrations. The
aqueous solutions and n-octanol (1 : 1 ratio) were gently mixed
with 360° vertical rotation (∼20 rpm) for 3 h to avoid emulsion
formation, and the mixtures were centrifuged at 5000 rpm for
3 min by a temperature controlled centrifuge (Sanyo) at 25 °C.
After separation, UV−vis spectra of the compounds in the
aqueous phase were compared to those of the original
aqueous solutions and D7.4 values of the complexes or ligands
were calculated as follows: [absorbance (original solution)/
absorbance (aqueous phase after separation) − 1].
Absorbances were recorded in the region of λmax (250–600 nm).
Synthesis of complex [chlorido(8-hydroxyquinolinato-κN1,κO8)
(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] (1)
and crystallographic structure determination
Single crystals suitable for X-ray diﬀraction experiment of com-
pound [Rh(η5-C5Me5)(8-quinolinolato)Cl] (1) were grown from
a water/ethanol solution mixture (2.0 mL) containing the HQ
ligand (2.9 mg, 0.02 mmol) and rhodium dimer [Rh(η5-C5Me5)
(μ-Cl)Cl]2 (6.2 mg, 0.01 mmol) at neutral pH (adjusted by
NaOH solution). The mixture was kept in the dark at room
temperature and after 4 h dark orange crystals were formed.
A single crystal was mounted on a loop and transferred to
the goniometer. X-ray diﬀraction data were collected at
−170 °C on a Rigaku RAXIS-RAPID II diﬀractometer using Mo-
Kα radiation. A multi-scan absorption correction was carried
out using the program CrystalClear.55 Sir201456 and SHELXL57
under the WinGX58 software were used for structure solution
and refinement, respectively. The structures were solved by
direct methods. The models were refined by full-matrix least
squares on F2. Refinement of non-hydrogen atoms was carried
out with anisotropic temperature factors. Hydrogen atom posi-
tions were located in diﬀerence electron density maps (for
water hydrogens) or placed into geometric positions. They
were included in structure factor calculations but they were
not refined. The isotropic displacement parameters of the
hydrogen atoms were approximated from the U(eq.) value of the
atom they were bonded to. The summary of data collection
and refinement parameters for complex [Rh(η5-C5Me5)(8-qui-
nolinolato)Cl]·3H2O are collected in Table S1.† Selected bond
lengths and angles of compounds were calculated by using the
PLATON software.42 The graphical representation and the
edition of CIF files were done by using the Mercury59 and
PublCif60 software. The crystallographic data files for the
complexes have been deposited with the Cambridge
Crystallographic Database as CCDC 1530884.
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The orange crystals were filtered and analyzed by 1H NMR
(500.13 MHz, CD3OD): δ (ppm) 8.82 (m, 1H, CH2); 8.28 (d,
3J (H,H) = 8 Hz, 1H, CH4); 7.56 (m 1H, CH6); 7.36 (t, 3J (H,H) =
8 Hz, 1H, CH3); 6.97 (d, 3J (H,H) = 8 Hz, 1H, CH5); 6.94 (d,
3J (H,H) = 8 Hz, 1H, CH7); 1.72 (s, 15H, CH3, C5Me5) and by
ESI-MS: m/z = 382 [complex − Cl−]+. NMR and ESI-MS data
obtained are similar to those published by Sliwinska et al.19
and Thai et al.22
Cell lines, culture conditions and cytotoxicity tests in cancer
cell lines
Cell lines and culture conditions. The human uterine
sarcoma cell lines MES-SA and the doxorubicin selected
MES-SA-MES-SA/Dx5 were obtained from ATCC (American Type
Culture Collection) (MES-SA: No. CRL-1976™,
MES-SA-MES-SA/Dx5: No. CRL-1977™). The phenotype of the
resistant cells was verified using cytotoxicity assays (Table 5,
Doxorubicin). Cells were cultivated in Dulbecco’s Modified
Eagle Medium (DMEM, Sigma-Aldrich) and supplemented
with 10% fetal bovine serum, 5 mmol L−1 glutamine, and 50
units per mL penicillin and streptomycin (Life Technologies).
All cell lines were cultivated at 37 °C under a humidified atmo-
sphere containing 95% air and 5% CO2.
Cell viability assay. Cytotoxic eﬀects were determined by
means of the colorimetric microculture MTT assay.61 For this
purpose, the cells were harvested from culture flasks by trypsi-
nization, seeded in 100 μL per well aliquots into 96-well micro-
culture plates (Sarstedt, Newton, USA) at 5 000 cells per well
and allowed to settle and resume exponential growth in drug-
free complete culture medium for 12 h to 24 h. Ligands HQ,
PHQ and HQS were dissolved in an 80% (v/v) ethanol/water
mixture first, diluted in complete culture medium and added
to the plates where the final ethanol content did not exceed
0.5%. Whereas the Rh(η5-C5Me5) and Ru(η6-p-cymene) com-
plexes of the ligands were prepared in an 80% (v/v) ethanol/
water mixture in situ by mixing the ligand with one equimolar
concentration of the organometallic cations using their stock
solutions containing known amounts of [Rh(η5-C5Me5)
(H2O)3]
2+ and [Ru(η6-p-cymene)(H2O)3]2+. Following the
addition of the serial dilutions of ligands and complexes and
an incubation period of 72 h, the supernatant was removed
and fresh medium supplemented with the MTT reagent
(0.83 mg mL−1) was added. Incubation with MTT at 37 °C was
terminated after 1 h by removing the supernatants and lysing
the cells with 100 µL DMSO per well. Viability of the cells was
measured spectrophotometrically by absorbance at 540 nm
using an EnSpire microplate reader. The data were background
corrected by subtraction of the signal obtained from unstained
cell lysates and normalized to untreated cells. Curves were
fitted by using the Prism software62 using the sigmoidal dose–
response model (comparing variable and fixed slopes). Curve
fit statistics were used to determine the concentration of the
test compound that resulted in 50% toxicity (IC50). Evaluation
is based on means from three independent experiments, each
comprising three replicates per concentration level. Co-incu-
bation experiments were also performed in the presence of the
P-gp inhibitor TQ (kind gift of Dr S. Bates, NCI NIH).
Doxorubicin (Sigma-Aldrich) was used as a positive control.
Conclusions
The rational design and optimization of the bioactivity of
metallodrugs require detailed information about the solution
behavior, stability and speciation characteristics, especially
under physiological conditions. Solution equilibrium studies
provide information about the chemical species present in
aqueous solution and are of utmost importance for the under-
standing of the mechanism of action of biologically active
compounds. The main objective of this work was to character-
ize and compare the solution speciation of Ru(η6-p-cymene)
and Rh(η5-C5Me5) complexes formed with various bidentate
8-hydroxyquinoline compounds (HQ, PHQ and HQS).
Stoichiometry and stability of these organometallic complexes
were determined in aqueous solution via a combined approach
using 1H NMR spectroscopy, UV-visible spectro-photometry
and pH-potentiometry. X-ray diﬀraction study of [Rh(η5-C5Me5)
(8-quinolinolato)(Cl)] showed a pseudo-octahedral “piano-
stool” geometry, and the deprotonated ligand coordinates in a
bidentate mode via (N,O−) donor atoms. Based on the com-
parative equilibrium studies we concluded that mono-ligand
complexes with a general formula of [M(L)(H2O)] are formed
with significantly high solution stability, and their decompo-
sition cannot occur even at low micromolar concentrations at
physiological pH. The trend for the stability of the studied
organometallic complexes is the following: HQS > HQ > PHQ.
The relative aﬃnities of the 8-hydroxyquinolines towards the
organometallic cations are somewhat higher with Rh(η5-
C5Me5) at pH 7.4. However, 1–1.5 orders of magnitude lower
pKa values were obtained for the [Ru(η6-p-cymene)(L)(H2O)]
complexes, mixed hydroxido species [M(L)(OH)] are formed
only in the basic pH range in all cases due to the relatively
high pKa values (8.5–10.3). Notably, the complex formation
rate with [Ru(η6-p-cymene)(H2O)3]2+ is much lower compared
to the organorhodium triaqua cation. Additionally, H2O/Cl
−
co-ligand exchange constants show the stronger aﬃnity of the
Rh(η5-C5Me5) complexes towards chloride ions. As a conse-
quence of the aquation of the chlorinated compounds ([M(L)
(Cl)]) the lipophilic character of the studied organometallic
complexes is decreasing with decreasing chloride ion concen-
trations. A somewhat stronger hydrophilic character of the Ru
(η6-p-cymene) complexes was found at chloride ion concen-
trations which are biologically relevant.
In vitro cytotoxicity of the unsubstituted HQ, as well as of
the substituted derivatives PHQ (which is preferentially toxic
to multidrug resistant cell lines) and HQS was measured in the
absence and in the presence of the [Ru(η6-p-cymene)(H2O)3]2+
and [Rh(η5-C5Me5)(H2O)3]2+ cations. A cell line pair, namely
MES-SA (human uterine sarcoma) and its P-gp-expressing
multidrug resistant counterpart (MES-SA/Dx5), was used. IC50
values in the low μM range were observed except for the HQS
containing samples. The eﬀect of Tariquidar, a high-aﬃnity
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P-gp inhibitor, on the selectivity ratio was also investigated.
Ligand HQ and its organometallic complexes exhibit a similar
cytotoxicity in both cell lines, with a low selectivity ratio that is
unaﬀected by the complexation and P-gp activity. At the same
time PHQ and its Rh(η5-C5Me5) complex have an increased
P-gp mediated MDR-selective ratio, however the selectivity is
abrogated in the case of the Ru(η6-p-cymene) complex, which
might be a consequence of its more inert feature and slightly
more hydrophilic character.
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